Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: May 2008
-
By Christopher P. Singer — Last month, the U.S. Patent and Trademark Office announced that it had updated the training materials to be used by examiners in the examination of patent applications for compliance with the written description requirement of 35 U.S.C. § 112, first paragraph. The revised training materials supersede and replace…
-
By Christopher P. Singer — Last month, the U.S. Patent and Trademark Office announced that it had updated the training materials to be used by examiners in the examination of patent applications for compliance with the written description requirement of 35 U.S.C. § 112, first paragraph. The revised training materials supersede and replace…
-
By Kevin E. Noonan — Ever since it was discovered by European explorers at the end of the 18th Century, the duckbill platypus (Ornithorhynchus anatinus) has been a biological anomaly. Fur-bearing and lactating like a mammal (although lactation is through the abdominal wall because the animal lacks nipples), the platypus reproduces by egg-laying…
-
By Kevin E. Noonan — As reported by Patent Docs on April 30th, Jon Dudas (at right), Undersecretary of Commerce and Director of the U.S. Patent and Trademark Office, has a message for the public (and Congress, and the courts and particularly the patent community): one of the problems that ails the Patent…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. StemCells, Inc. et al. v. Neuralstem, Inc. et al.4:08-cv-02364; filed May 7, 2008 in the Northern District of California Infringement of U.S.…
-
May 15, 2008 – The Federal Circuit: A National Court of Appeals: Addressing New Challenges (U.S. Court of Appeals for the Federal Circuit) – Washington, DC May 28, 2008 – Advanced Patent Licensing 2008: What You Need to Know Before Licensing Your Patent (Practising Law Institute) – New York, NY May 28-30, 2008 – PharmaBiotech…
-
Law Seminars International (LSI) will be holding its fourth annual conference on Current Issues in Complex IP Licensing on September 11-12, 2008 in Philadelphia, PA. The workshop will provide information on: • How to get what you want out of the deal;• Legal update on major recent and pending cases;• The fallout from the Tafas/GlaxoSmithKline…
-
By Donald Zuhn — Last month, the U.S. Patent and Trademark Office announced that it had updated the training materials to be used by examiners in the examination of patent applications for compliance with the written description requirement of 35 U.S.C. § 112, first paragraph. The revised training materials supersede and replace the…
-
By Kevin E. Noonan — The U.S. Patent and Trademark Office filed a Notice of Appeal today with the Court of Appeals for the Federal Circuit, challenging the decision of Judge William Cacheris of the Eastern District of Virginia permanently enjoining the continuation and claims rules as being outside the scope of their…
-
An Analysis of the New Written Description Training Materials – DNA Hybridization & Percent Identity
By Donald Zuhn — Last month, the U.S. Patent and Trademark Office announced that it had updated the training materials to be used by examiners in the examination of patent applications for compliance with the written description requirement of 35 U.S.C. § 112, first paragraph. The revised training materials supersede and replace the…
Patent Docs 